Although Klason is generally credited as being the first to use sulfuric acid for lignin analysis, Sherrard and Harris (11 ) credit the use of sulfuric acid to Fleschsig in 1883, Ost and Wilkening in 1912, and König and Rump in 1913. According to Harris (12 ), Fleschsig, in 1883, dissolved cotton cellulose and converted it nearly quantitatively into sugars using strong sulfuric acid followed by dilution and heating. According to Browning (13 ), Ost and Wilkening introduced the use of 72 wt % sulfuric acid for lignin determinations in 1910. A translated paper by Heuser (14 ) credited König and Ost and Wilkening for the sulfuric acid lignin method. Dore (15 ) described several improved analytical methods (cellulose, lignin, soluble pentosans, mannan, and galactan) for the summative analysis of coniferous woods. The discrepancies in attribution may be due to differing definitions for the method cited (e.g., first to use acid to determine lignin, first to use sulfuric acid, first to use 72 wt % sulfuric acid, etc.) and to missed citations across continental distances in the early 20th century.
Cellulose
This structural component of plants consists of long chains of glucose units linked by beta-1,4-glycosidic bonds.
Cellulose exhibits remarkable properties, including high tensile strength, biodegradability, and the ability to be chemically modified.
Researchers leverage these characteristics to develop novel cellulose-based products and optimixe production processes.
PubCompare.ai's AI-driven tools can help accelerate cellulose-related discoveries by identifying the best protocols and products from the literature, preprints, and patents.
Seamless collaboration and reproducible research are key to unlocking the full potential of this renewable resource.
Most cited protocols related to «Cellulose»
Although Klason is generally credited as being the first to use sulfuric acid for lignin analysis, Sherrard and Harris (11 ) credit the use of sulfuric acid to Fleschsig in 1883, Ost and Wilkening in 1912, and König and Rump in 1913. According to Harris (12 ), Fleschsig, in 1883, dissolved cotton cellulose and converted it nearly quantitatively into sugars using strong sulfuric acid followed by dilution and heating. According to Browning (13 ), Ost and Wilkening introduced the use of 72 wt % sulfuric acid for lignin determinations in 1910. A translated paper by Heuser (14 ) credited König and Ost and Wilkening for the sulfuric acid lignin method. Dore (15 ) described several improved analytical methods (cellulose, lignin, soluble pentosans, mannan, and galactan) for the summative analysis of coniferous woods. The discrepancies in attribution may be due to differing definitions for the method cited (e.g., first to use acid to determine lignin, first to use sulfuric acid, first to use 72 wt % sulfuric acid, etc.) and to missed citations across continental distances in the early 20th century.
To calculate the CI of cellulose from the XRD spectra, three different methods were used. First, CI was calculated from the height ratio between the intensity of the crystalline peak (I002 - IAM) and total intensity (I002) after subtraction of the background signal measured without cellulose [17 (link)-19 (link)] (Figure
Solid-state 13C NMR spectra were collected at 4.7 T with cross-polarization and magic angle spinning (MAS) in a 200 MHz spectrometer (Avance; Bruker, Madison, WI, USA). Variable amplitude cross-polarization was used to minimize intensity variations of the non-protonated aromatic carbons that are sensitive to Hartmann-Hahn mismatch at higher MAS rotation rates [22 ]. The 1H and 13C fields were matched at 53.6 kHz, and a 1 dB ramp was applied to the proton rotating-frame during the matching period. Acquisition time was 0.051 seconds, and sweep-width was 20 kHz. MAS was performed at 6500 Hz. The number of scans was 10,000 to 20,000 with a relaxation time of 1.0 seconds. The CI was determined by separating the C4 region of the spectrum into crystalline and amorphous peaks, and calculated by dividing the area of the crystalline peak (87 to 93 ppm) by the total area assigned to the C4 peak (80 to 93 ppm) [23 (link)] (Figure
An overview of the process is shown in Fig.
Schematic overview of the 1G + 2G process and alternative configurations
To determine whether different types of filters would influence the recovery rates of analytes, each standard (5 ng) was added into a 1.5-mL tube, mixed with the same amount of cold extraction buffer, vigorously shaken on a shaking bed, and centrifuged as described above. The samples were then filtered using a nylon filer or a syringe-facilitated 13-mm diameter cellulose filter with pore size 0.22 μm (MCE; Navigator Lab Instrument Co., Ltd, Tianjing, China). The filtrates were dried and then dissolved in methanol as described above.
For comparison, samples were also prepared using a solid-phase extraction procedure [16 (link)]. In brief, ground sample powder was mixed with 2 ml extraction buffer and shaken on a shaking bed for 16 h as for the above-described preparation for crude extraction, and then centrifuged at 3500 g for 15 min at 4°C for collecting the supernatant. The supernatant was purified using a C18-SepPak cartridge (Waters Corporation, Milford, MA, USA) by a series of steps. The purified sample was dried by evaporation and then dissolved in 200 μL of methanol as described above for preparation for the crude extraction.
Most recents protocols related to «Cellulose»
Example 3
Probe Materials
A number of porous materials were tested to generate charged droplets for mass spectrometry. The materials were shaped into triangles having sharp tips and sample solution was then applied to the constructed probes. Data herein show that any hydrophilic and porous substrate could be used successfully, including cotton swab, textile, plant tissues as well as different papers. The porous network or microchannels of these materials offered enough space to hold liquid and the hydrophilic environment made it possible for liquid transport by capillary action. Hydrophobic and porous substrates could also be used successfully with properly selected hydrophobic solvents.
For further investigation, six kinds of commercialized papers were selected and qualitatively tested to evaluate their capabilities in analyte detection. Filter papers and chromatography paper were made from cellulose, while glass microfiber filter paper was made from glass microfiber.
It was hypothesized that the glass fiber paper was working on mode II and prohibiting efficient droplet generation, due to the relative large thickness (˜2 mm). This hypothesis was proved by using a thin layer peeled from glass fiber paper for cocaine detection. In that case, the intensity of the background increased and a cocaine peak was observed. All filter papers worked well for cocaine detection, (
Probe Shape and Tip Angle
Many different probe shapes were investigated with respect to generating droplets. A preferred shape of the porous material included at least one tip. It was observed that the tip allowed ready formation of a Taylor cone. A probe shape of a triangle was used most often. As shown in
Example 2
N-(2-chloro-4-(trifluoromethyl)phenyl)-2-(5-ethyl-2-morpholino-7-oxo-6-(piperazin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-4(7H)-yl)acetamide (Intermediate B) (200 mg, 352 μmol) was suspended in DMF (5 mL). Perfluorophenyl 3-hydroxypicolinate (Intermediate CT) (215 mg, 703 μmol) and Et3N (97.0 μL, 703 μmol) were added and the RM was stirred at 70° C. for 3 hours. The RM was concentrated under reduced pressure. The crude product was first purified by column chromatography (Silica gel column: Silica 12 g, eluent DCM:MeOH 100:0 to 90:10). Then a second purification by reverse phase preparative HPLC (RP-HPLC acidic 9: 40 to 50% B in 2 min, 50 to 55% B in 10 min) afforded the title compound.
LC-MS: Rt=0.98 min; MS m/z [M+H]+ 690.6/692.6, m/z [M−H]− 688.4/690.3; UPLC-MS 1
LC-MS: Rt=4.84 min; MS m/z [M+H]+ 690.2/692.2 m/z [M−H]− 688.3/690.3; UPLC-MS 2
1H NMR (400 MHz, DMSO-d6) δ 10.37 (s, br, 1H), 10.34 (s, br, 1H), 8.05 (m, 2H), 7.96 (d, J=2.1 Hz, 1H), 7.72 (dd, J=2.1 Hz, 8.7 Hz, 1H), 7.28 (m, 2H), 5.21 (s, 2H), 4.53 (m, 1H), 3.66 (m, 4H), 3.46 (m, 3H), 3.38 (m, 4H), 3.20 (m, 1H), 2.92 (m, 3H), 2.76 (m, 1H), 2.58 (m, 1H), 1.16 (t, J=7.5 Hz, 3H)
Example 24
To the stirred solution of N-(2-chloro-6-(trifluoromethyl)pyridin-3-yl)-2-(5-ethyl-2-(4-methoxycyclohex-1-en-1-yl)-7-oxo-6-(piperazin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-4(7H)-yl)acetamide (Intermediate Y) (300 mg, 504 μmol), 4-chloro-3-hydroxypicolinic acid (140 mg, 807 μmol), HOBt (136 mg, 1.01 mmol) and EDC.HCl (193 mg, 1.01 mmol) in DCM (20 mL) was added pyridine (122 μL, 1.51 mmol) at 0° C. The RM was stirred at RT for 16 hours. The RM was quenched with NaHCO3 and extracted with DCM. The organic layer was dried over Na2SO4 and concentrated under reduced pressure. The crude product was purified by column chromatography (Silica gel column: Silica 4 g, eluent DCM:MeOH 100:0 to 98:2). The residue was purified by preparative chiral HPLC (instrument: Agilent 1200 series, with single quad mass spectrometer; column: LUX CELLULOSE-4, 250 mm×21.1 mm, 5.0 μm; eluent: A=hexane, B=0.1% HCOOH in EtOH; flow rate: 15 mL/min; detection: 210 nm; injection volume: 0.9 mL; gradient: isocratic: 50(A):50(B)).
Example 24a: The product containing fractions were concentrated at 40° C. and washed with n-pentane (5×10 mL), decanted and dried to give the title compound as an off-white solid—first eluting stereoisomer.
Chiral HPLC (C-HPLC 2): Rt=10.764 min
LC-MS: Rt=1.08 min; MS m/z [M+H]+ 750.5/752.5, m/z [M−H]− 748.4/750.4; UPLC-MS 1
LC-MS: Rt=5.29 min; MS m/z [M+H]+ 750.2/752.2, m/z [M−H]− 748.2/750.2; UPLC-MS 2
1H NMR (400 MHz, DMSO-d6) δ 10.68 (s, br, 2H), 8.56 (d, J=8.1 Hz, 1H), 7.98 (d, J=5.6 Hz, 1H), 7.94 (d, J=8.1 Hz, 1H), 7.50 (d, J=5.1 Hz, 1H), 6.72 (m, 1H), 5.34 (s, 2H), 4.53 (m, 1H), 3.52 (m, 4H), 3.28 (m, 4H), 2.98 (m, 3H), 2.80 (m, 1H), 2.63 (m, 1H), 2.55 (m, 1H), 2.46 (m, 1H), 2.16 (m, 2H), 1.95 (m, 1H), 1.68 (m, 1H), 1.17 (t, J=7.3 Hz, 3H)
Example 24b: The product containing fractions were concentrated at 40° C. and washed with n-pentane (5×10 mL), decanted and dried to give the title compound as an off-white solid—second eluting stereoisomer.
Chiral HPLC (C-HPLC 2): Rt=18.800 min
LC-MS: Rt=1.08 min; MS m/z [M+H]+ 750.1/752.1, m/z [M−H]− 748.2/750.2; UPLC-MS 1
LC-MS: Rt=5.30 min; MS m/z [M+H]+ 750.1/752.1, m/z [M−H]− 748.2/750.2; UPLC-MS 2
1H NMR (400 MHz, DMSO-d6) δ 10.83 (s, br, 1H), 10.55 (s, br, 1H), 8.56 (d, J=8.2 Hz, 1H), 8.06 (d, J=5.3 Hz, 1H), 7.92 (d, J=8.2 Hz, 1H), 7.55 (d, J=5.3 Hz, 1H), 6.72 (m, 1H), 5.35 (s, 2H), 4.54 (m, 1H), 3.54 (m, 4H), 3.28 (m, 3H), 3.25 (m, 1H), 2.99 (m, 3H), 2.81 (m, 1H), 2.62 (m, 1H), 2.41 (m, 2H), 2.16 (m, 2H), 1.96 (m, 1H), 1.66 (m, 1H), 1.18 (t, J=7.3 Hz, 3H)
Example 25
N-(2-chloro-6-(trifluoromethyl)pyridin-3-yl)-2-(5-ethyl-2-(4-methoxycyclohex-1-en-1-yl)-7-oxo-6-(piperazin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-4(7H)-yl)acetamide.HCl (Intermediate Y) (120 mg, 190 μmol) and DIPEA (166 μL, 950 μmol) were dissolved in DCM (5 mL) and then 3-hydroxypicolinoyl chloride (Intermediate CV) (59.9 mg, 380 μmol) was added at 0° C. and stirred for 2 hours. 3-hydroxypicolinoyl chloride (Intermediate CV) (59.9 mg, 380 μmol) was added again and the reaction was continued under stirring for 12 hours. The RM was diluted with DCM and washed with water and aq NaHCO3 (2×20 mL), washed with water and brine, dried over Na2SO4, filtered and concentrated. The crude product was combined with another experiment and purified by column chromatography (Silica gel column: Silica 4 g, eluent DCM:MeOH 100:0 to 99:1) then further purified by reverse phase preparative HPLC (RP-HPLC acidic 10: 40 to 50% B in 2 min, 50 to 60% B in 8 min) to give the title compound as an off-white solid.
The racemate was purified by preparative chiral HPLC (instrument: Agilent 1200 series, with single quad mass spectrometer; column: CELLULOSE-4, 250 mm×21.2 mm; eluent: A=hexane, B=0.1% HCOOH in MeOH:EtOH 1:1; flow rate: 20 mL/min; detection: 210 nm; injection volume: 0.9 mL; gradient: isocratic 60(A):40(B)).
Example 25a: First eluting stereoisomer, off-white solid.
Chiral HPLC (C-HPLC 1): Rt=10.070 min
LC-MS: Rt=0.98 min; MS m/z [M+H]+ 716.5/718.6, m/z [M−H]− 714.3/716.3; UPLC-MS 1
LC-MS: Rt=4.76 min; MS m/z [M+H]+ 716.2/718.2, m/z [M−H]− 714.2/716.2; UPLC-MS 2
1H NMR (400 MHz, DMSO-d6) δ 10.46 (s, br, 2H), 8.56 (d, J=8.5 Hz, 1H), 8.05 (m, 1H), 7.90 (d, J=8.4 Hz, 1H), 7.28 (m, 2H), 6.72 (m, 1H), 5.30 (s, 2H), 4.54 (m, 1H), 3.47 (m, 4H), 3.27 (s, 3H), 3.21 (m, 1H), 2.96 (m, 3H), 2.79 (m, 1H), 2.59 (m, 3H), 2.43 (m, 1H), 2.14 (m, 1H), 1.95 (m, 1H), 1.67 (m, 1H), 1.17 (t, J=7.2 Hz, 3H)
Example 25b: Second eluting stereoisomer, off-white solid.
Chiral HPLC (C-HPLC 1): Rt=16.023 min
LC-MS: Rt=0.96 min; MS m/z [M+H]+ 716.3/718.3, m/z [M−H]− 714.3/716.3; UPLC-MS 1
LC-MS: Rt=4.77 min; MS m/z [M+H]+ 716.2/718.2, m/z [M−H]− 714.2/716.2; UPLC-MS 2
1H NMR (400 MHz, DMSO-d6) δ 10.39 (s, br, 2H), 8.56 (d, J=8.0 Hz, 1H), 8.06 (m, 1H), 7.93 (d, J=8.1 Hz, 1H), 7.28 (m, 2H), 6.72 (m, 1H), 5.32 (s, 2H), 4.54 (m, 1H), 3.46 (m, 4H), 3.27 (s, 3H), 3.20 (m, 1H), 2.96 (m, 3H), 2.79 (m, 1H), 2.59 (m, 3H), 2.41 (m, 1H), 2.14 (m, 1H), 1.95 (m, 1H), 1.68 (m, 1H), 1.17 (t, J=7.1 Hz, 3H)
Example 1
Exemplary capsule shell and matrix compositions useful for producing Liquisoft capsules as described herein are shown in Table 4. Composition components are set forth by weight percentage of the total weight of the composition. Such compositions may be encapsulated using rotary die encapsulation as described herein.
Formulas 1 and 2 were the first shell formulations developed to achieve faster disintegration time and prevent crosslinking of the gelatin shell with matrix fill components.
Example 2
To 1-methyl-2-oxo-1-azaspiro[4.5]decan-8-yl 4-methylbenzenesulfonate (Int III-1) (1.4 g, 4.2 mmol) was added DMF (15 mL), N-(imidazo[1,2-b]pyridazin-3-yl)-6-methoxy-1H-indazole-5-carboxamide (Int II-1) (1.3 g, 4.2 mmol) and KOH (466 mg, 8.3 mmol). The resulting solution was stirred at 100° C. After 12 h the reaction mixture was allowed to cool to rt and directly purified using C18-flash chromatography (eluting with 0% to 100% MeCN in water (0.05% FA)) followed by chiral HPLC (CHIRAL ART Cellulose-SB, 2×25 mm, 5 μm; mobile Phase A: MTBE (2 mm NH3 in MeOH); mobile Phase B: i-PrOH; gradient: isocratic 50% B for 21.5 min; flow rate: 20 mL/min) to afford N-(imidazo[1,2-b]pyridazin-3-yl)-6-methoxy-2-((5s,8s)-1-methyl-2-oxo-1-azaspiro[4.5]decan-8-yl)-2H-indazole-5-carboxamide (28.0 mg, 1%) as a yellow solid. 1H NMR (300 MHz, CD3OD) δ 8.75 (d, 1H), 8.62 (s, 1H), 8.59 (d, 1H), 8.15 (s, 1H), 8.04 (dd, 1H), 7.21-7.28 (m, 2H), 4.71-4.79 (m, 1H), 4.23 (s, 3H), 2.68 (s, 3H), 2.59-2.69 (m, 2H), 2.44 (t, 2H), 2.07-2.33 (m, 6H), 1.45-1.55 (m, 2H). m/z (ESI+), [M+H]+=474.
Example 2
BC non-woven was produced by the method of the present invention. In particular, BC non-woven was sterilized with e-beam or by exposure to steam after removal from the culture vessel and separation from the BC that remained in the culture vessel. The BC network structure was investigated with scanning electron microscopy. It was found that the network structure was neither disturbed by sterilization with steam nor by e-beam sterilization.